
Reset all filters
01 3Gowling WLG
02 6Gowling WLG (Canada) LLP
Reset all filters
01 32812363
02 32984130
03 33033180
Reset all filters
01 9BALOXAVIR MARBOXIL
Reset all filters
01 9TABLET
Reset all filters
01 32031-09-21
02 32036-04-27
03 32037-08-09
Patent Expiration Date : 2031-09-21
Date Granted : 2019-04-02
Brand Name : XOFLUZA
Patent Number : 2812363
Filing Date : 2011-09-21
Strength per Unit : 20mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-09-21
Date Granted : 2019-04-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-09-21
Date Granted : 2019-04-02
Brand Name : XOFLUZA
Patent Number : 2812363
Filing Date : 2011-09-21
Strength per Unit : 40mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-09-21
Date Granted : 2019-04-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2036-04-27
Date Granted : 2021-07-20
Brand Name : XOFLUZA
Patent Number : 2984130
Filing Date : 2016-04-27
Strength per Unit : 20mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2036-04-27
Date Granted : 2021-07-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2037-08-09
Date Granted : 2022-05-31
Brand Name : XOFLUZA
Patent Number : 3033180
Filing Date : 2017-08-09
Strength per Unit : 20mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2037-08-09
Date Granted : 2022-05-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2036-04-27
Date Granted : 2021-07-20
Brand Name : XOFLUZA
Patent Number : 2984130
Filing Date : 2016-04-27
Strength per Unit : 40mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2036-04-27
Date Granted : 2021-07-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2037-08-09
Date Granted : 2022-05-31
Brand Name : XOFLUZA
Patent Number : 3033180
Filing Date : 2017-08-09
Strength per Unit : 40mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2037-08-09
Date Granted : 2022-05-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-09-21
Date Granted : 2019-04-02
Brand Name : XOFLUZA
Patent Number : 2812363
Filing Date : 2011-09-21
Strength per Unit : 80mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-09-21
Date Granted : 2019-04-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2036-04-27
Date Granted : 2021-07-20
Brand Name : XOFLUZA
Patent Number : 2984130
Filing Date : 2016-04-27
Strength per Unit : 80mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2036-04-27
Date Granted : 2021-07-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2037-08-09
Date Granted : 2022-05-31
Brand Name : XOFLUZA
Patent Number : 3033180
Filing Date : 2017-08-09
Strength per Unit : 80mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2037-08-09
Date Granted : 2022-05-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF